Detalles de la búsqueda
1.
SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Breast Cancer Res
; 20(1): 60, 2018 06 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29921289
2.
Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients.
Breast Cancer Res Treat
; 154(3): 483-94, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26585578
3.
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Breast Cancer Res Treat
; 151(2): 373-84, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25935582
4.
Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.
Br J Haematol
; 161(3): 373-82, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23431957
5.
Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.
Eur J Haematol
; 91(3): 196-200, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23607294
6.
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer.
Acta Oncol
; 52(1): 82-90, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23205744
7.
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
Breast Cancer Res Treat
; 134(1): 207-17, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22294488
8.
Subtyping of male breast cancer by PAM50 and immunohistochemistry: a pilot study of a consecutive Danish cohort.
APMIS
; 128(9): 523-530, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32579768
9.
Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.
Breast Cancer Res
; 11(1): R11, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19239686
10.
Identification of genes for normalization of real-time RT-PCR data in breast carcinomas.
BMC Cancer
; 8: 20, 2008 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-18211679
11.
Coexisting genomic aberrations associated with lymph node metastasis in breast cancer.
J Clin Invest
; 128(6): 2310-2324, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29558370
12.
Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array.
Cell Oncol
; 29(5): 361-72, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17726259
13.
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence.
Nat Med
; 23(11): 1319-1330, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28967919
14.
Prospective validation of a blood-based 9-miRNA profile for early detection of breast cancer in a cohort of women examined by clinical mammography.
Mol Oncol
; 10(10): 1621-1626, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27839676
15.
High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor-Positive Metastatic Breast Cancer.
Clin Cancer Res
; 22(22): 5514-5526, 2016 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27252418
16.
Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer.
Oncotarget
; 7(35): 57239-57253, 2016 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27528030
17.
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
JAMA Oncol
; 2(2): 217-24, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26633571
18.
miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.
Oncotarget
; 6(30): 29224-39, 2015 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26317550
19.
Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease.
Leuk Lymphoma
; 55(4): 911-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23915193
20.
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Mol Oncol
; 8(5): 874-83, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24694649